Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow

被引:3
|
作者
Patel, Shivani G. [1 ,2 ]
Husain, Nazia [1 ,2 ]
Rigsby, Cynthia K. [2 ,3 ,4 ]
Robinson, Joshua D. [1 ,2 ,4 ]
机构
[1] Ann & Robert H Lurie Childrens Hosp Chicago, Div Cardiol, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA
[3] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Med Imaging, Chicago, IL 60611 USA
[4] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA
来源
CHILDREN-BASEL | 2022年 / 9卷 / 09期
关键词
pediatric; stress perfusion MRI; regadenoson; CARDIOVASCULAR MAGNETIC-RESONANCE; CORONARY-ARTERY-DISEASE; EMISSION COMPUTED-TOMOGRAPHY; RESERVE;
D O I
10.3390/children9091332
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Myocardial stress perfusion magnetic resonance imaging is a non-invasive tool to assess for myocardial ischemia and viability. Pediatric myocardial stress perfusion MRI can be challenging due to multiple intravenous lines, sedation, inadequate breath holding, fast heart rates, and complex anatomy. We performed a retrospective analysis in 39 children to evaluate safety and efficacy of regadenoson, a coronary vasodilator administered via a single intravenous line (6-10 mcg/kg), with respiratory motion correction (MOCO) and semi-quantitative blood flow analysis. Stress response data and adverse events were recorded, and image quality compared between native and MOCO reconstructions, assessing for perfusion deficits. Semi-quantitative analysis compared myocardial perfusion reserve index (MPRI) between patients who had a focal perfusion defect, patients who had undergone an orthotopic heart transplant, and non-transplant patients with no focal defects. Stress perfusion was completed in 38/39 patients (median age 15 years with a 41 +/- 27% rise in heart rate (p < 0.005). Fifteen out of thirty-eight had transient minor side effects with no major adverse events. MOCO image quality was better than non-MOCO (4.63 vs. 4.01 at rest, p < 0.005: 4.41 vs. 3.84 at stress, p < 0.005). Reversible perfusion defects were seen in 4/38 patients with lower segmental mean MPRI in the area of the perfusion defect, nearing statistical significance when compared to non-transplant patients with no defects (0.78 +/- 0.22 vs. 0.99 +/- 0.36, p = 0.07). The global MPRI of the 16 patients who had undergone orthotopic heart transplant was significantly lower than the non-transplant patients (0.75 +/- 0.22 vs. 0.92 +/- 0.23, p = 0.03). Regadenoson is a safe and effective coronary vasodilator for pediatric stress perfusion MRI with MOCO producing better image quality and allowing for semi-quantitative assessment of perfusion deficits that correlate with qualitative assessment.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Performance and safety profile of regadenoson myocardial perfusion imaging: first experience in Greece
    Koutsikos, John
    Angelidis, George
    Zafeirakis, Athanasios
    Mamarelis, Ioannis
    Vogiatzis, Merkourios
    Ilia, Eliverta
    Lazaridis, Kyriakos
    Demakopoulos, Nikolaos
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2017, 20 (03): : 232 - 236
  • [42] Myocardial Blood Flow Quantification from MRI - an Image Analysis Perspective
    Zarinabad N.
    Chiribiri A.
    Breeuwer M.
    Current Cardiovascular Imaging Reports, 2014, 7 (1) : 1 - 9
  • [43] Myocardial blood flow quantification with MRI by model-independent deconvolution
    Jerosch-Herold, M
    Swingen, C
    Seethamraju, RT
    MEDICAL PHYSICS, 2002, 29 (05) : 886 - 897
  • [44] Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial
    M. I. Ross
    E. Wu
    J. T. Wilkins
    D. Gupta
    S. Shen
    D. Aulwes
    K. Montero
    T. A. Holly
    Journal of Nuclear Cardiology, 2013, 20 : 197 - 204
  • [45] Quantification of pain-induced changes in cerebral blood flow by perfusion MRI
    Owen, D. G.
    Bureau, Y.
    Thomas, A. W.
    Prato, F. S.
    Lawrence, K. S. St.
    PAIN, 2008, 136 (1-2) : 85 - 96
  • [46] Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial
    Ross, M. I.
    Wu, E.
    Wilkins, J. T.
    Gupta, D.
    Shen, S.
    Aulwes, D.
    Montero, K.
    Holly, T. A.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2013, 20 (02) : 197 - 204
  • [48] The role of acquisition and quantification methods in myocardial blood flow estimability for myocardial perfusion imaging CT
    Eck, Brendan L.
    Muzic, Raymond F., Jr.
    Levi, Jacob
    Wu, Hao
    Fahmi, Rachid
    Li, Yuemeng
    Fares, Anas
    Vembar, Mani
    Dhanantwari, Amar
    Bezerra, Hiram G.
    Wilson, David L.
    PHYSICS IN MEDICINE AND BIOLOGY, 2018, 63 (18):
  • [49] THE PROGNOSTIC VALUE OF REGADENOSON STRESS MYOCARDIAL PERFUSION IMAGING: THE LARGEST COHORT TO DATE
    Kattoor, Ajoe
    Iskander, Mina
    Iskander, Fady
    Khan, Rozi
    Doukky, Rami
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1578 - 1578
  • [50] Impact of exercise on regadenoson side effects during myocardial perfusion stress imaging
    Khandekar, Shashi
    Kwon, Deborah
    Brunken, Richard
    Cerqueira, Manuel
    Jaber, Wael
    Young, Ron
    Menon, Venu
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50